Works matching IS 11781653 AND DT 2021 AND VI 14 AND IP 6


Results: 16
    2
    5
    6
    7

    Patient-Reported Outcomes Through 1 Year of an HIV-1 Clinical Trial Evaluating Long-Acting Cabotegravir and Rilpivirine Administered Every 4 or 8 Weeks (ATLAS-2M).

    Published in:
    Patient, 2021, v. 14, n. 6, p. 849, doi. 10.1007/s40271-021-00524-0
    By:
    • Chounta, Vasiliki;
    • Overton, Edgar T.;
    • Mills, Anthony;
    • Swindells, Susan;
    • Benn, Paul D.;
    • Vanveggel, Simon;
    • van Solingen-Ristea, Rodica;
    • Wang, Yuanyuan;
    • Hudson, Krischan J.;
    • Shaefer, Mark S.;
    • Margolis, David A.;
    • Smith, Kimberly Y.;
    • Spreen, William R.
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16